Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 47.96%446.12M | 461.16%706.68M | 3,289.74%301.52M | 884.46%125.93M | 752.01%8.9M | 23,588.89%12.79M | --1.04M | --54K | ---- | ---- |
| Operating income | 47.96%446.12M | 461.16%706.68M | 3,289.74%301.52M | 884.46%125.93M | 752.01%8.9M | 23,588.89%12.79M | 1.04M | 54K | ||
| Cost of sales | -108.31%-146.73M | -422.44%-179.79M | -2,022.91%-70.44M | -640.88%-34.41M | -811.54%-3.32M | -20,095.65%-4.65M | ---364K | ---23K | ---- | ---- |
| Operating expenses | -108.31%-146.73M | -422.44%-179.79M | -2,022.91%-70.44M | -640.88%-34.41M | -811.54%-3.32M | -20,095.65%-4.65M | -364K | -23K | ||
| Gross profit | 29.56%299.4M | 475.72%526.88M | 4,043.43%231.08M | 1,023.33%91.52M | 720.15%5.58M | 26,180.65%8.15M | 680K | 31K | ||
| Selling expenses | -57.07%-314.75M | -119.55%-508.07M | -212.48%-200.39M | 29.16%-231.42M | 56.72%-64.13M | -64.87%-326.69M | -251.94%-148.16M | -496.01%-198.15M | ---42.1M | ---33.25M |
| Administrative expenses | -27.35%-110.8M | -51.42%-250.08M | -4.65%-87M | 40.28%-165.16M | 30.09%-83.13M | -13.96%-276.55M | -10.69%-118.91M | 12.65%-242.68M | ---107.43M | -415.93%-277.83M |
| Research and development expenses | 22.89%-195.22M | 2.23%-528.04M | 12.25%-253.16M | 33.30%-540.05M | 16.50%-288.49M | -32.00%-809.74M | -37.78%-345.51M | -62.54%-613.43M | ---250.77M | -150.13%-377.41M |
| Revaluation surplus | ---- | -100.83%-7K | --5.12M | --848K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of financial assets | ---- | -100.83%-7K | ---- | --848K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of other assets | ---- | ---- | --5.12M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | 116.23%58.81M | -308.25%-357.75M | -643.10%-362.29M | -107.63%-87.63M | -75.70%-48.75M | 4,015.37%1.15B | -365.43%-27.75M | 84,433.33%27.9M | ---5.96M | -99.88%33K |
| Operating profit | 60.61%-262.56M | -19.87%-1.12B | -39.19%-666.64M | -262.89%-931.89M | 25.13%-478.93M | 74.98%-256.8M | -57.45%-639.65M | -49.08%-1.03B | -406.26M | -290.92%-688.46M |
| Financing income | -62.69%12.77M | -13.69%73.02M | -37.49%34.23M | 157.27%84.61M | 1,075.59%54.76M | 36.66%32.89M | ---5.61M | 175.86%24.07M | ---- | ---31.73M |
| Financing cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --26.52M | ---- |
| Special items of earning before tax | ---- | -5.92%2.65M | ---- | 112.07%2.82M | 102.43%554K | -262.09%-23.36M | -576.94%-22.78M | 99.87%-6.45M | ---3.37M | -13,446.16%-4.94B |
| Earning before tax | 60.50%-249.79M | -23.32%-1.04B | -49.29%-632.41M | -241.51%-844.46M | 36.59%-423.61M | 75.49%-247.28M | -74.37%-668.04M | 82.17%-1.01B | -383.11M | -2,537.69%-5.66B |
| Tax | ---- | ---- | ---- | ---- | ---- | ---8K | ---- | ---- | ---- | ---- |
| After-tax profit from continuing operations | 60.50%-249.79M | -23.32%-1.04B | -49.29%-632.41M | -241.50%-844.46M | 36.59%-423.61M | 75.49%-247.28M | -74.37%-668.04M | 82.17%-1.01B | -383.11M | -2,537.69%-5.66B |
| Earning after tax | 60.50%-249.79M | -23.32%-1.04B | -49.29%-632.41M | -241.50%-844.46M | 36.59%-423.61M | 75.49%-247.28M | -74.37%-668.04M | 82.17%-1.01B | -383.11M | -2,537.69%-5.66B |
| Profit attributable to shareholders | 60.50%-249.79M | -23.32%-1.04B | -49.29%-632.41M | -241.50%-844.46M | 36.59%-423.61M | 75.49%-247.28M | -74.37%-668.04M | 82.17%-1.01B | -383.11M | -2,537.69%-5.66B |
| Basic earnings per share | 60.91%-0.77 | -20.00%-3.24 | -40.71%-1.97 | -225.30%-2.7 | 38.05%-1.4 | 75.87%-0.83 | -72.52%-2.26 | 94.81%-3.44 | -1.31 | -61.53%-66.29 |
| Diluted earnings per share | 60.91%-0.77 | -20.00%-3.24 | -40.71%-1.97 | -225.30%-2.7 | 38.05%-1.4 | 75.87%-0.83 | -72.52%-2.26 | 94.81%-3.44 | -1.31 | -61.53%-66.29 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.